Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Feb 26, 2026

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner		26 Feb 2026	6,600,000	1,298,482,620	-		-	UWM Paired Interests
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner		26 Feb 2026	6,600,000	8,664,911	-		-	Class A Common Stock
Prime Medicine Inc	Allan Reine	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	1,300,000	1,300,000	-		-	Stock Option (right to buy)
CompoSecure Inc (Class A)	David M. Cote	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	1,265,032	1,265,032	-		-	Stock Option (Right to Buy)
Unisys Corp	Michael M. Thomson	President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	1,234,568	1,963,541 (3%)	1%		0	Common Stock
CompoSecure Inc (Class A)	Thomas R. Knott	Director, See remarks, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	1,150,029	1,150,029	-		-	Stock Option (Right to Buy)
Alphabet (Class A)	Sundar Pichai	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	26 Feb 2026	1,111,464	1,707,060 (0%)	0%		0	Class C Capital Stock
Ovid Therapeutics Inc	Jeremy M. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	957,000	957,000	-		-	Employee Stock Option (Right to Buy)
Tillys Inc (Class A)	Nathan Michael Smith	Director, See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	26 Feb 2026	900,000	0	-		-	Stock Option (Right to Buy)
Tillys Inc (Class A)	Nathan Michael Smith	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	900,000	900,000	-		-	Stock Option (Right to Buy)
Tillys Inc (Class A)	Nathan Michael Smith	Director, See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	26 Feb 2026	900,000	0	-		-	Stock Option (Right to Buy)
Tillys Inc (Class A)	Nathan Michael Smith	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	900,000	900,000	-		-	Stock Option (Right to Buy)
SiriusPoint Ltd	Scott Egan	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	776,096	1,015,179 (1%)	0%		0	Common Shares
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 4.40 per share.	26 Feb 2026	632,874	2,697,785	-	4.4	2,784,646	Class A Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 4.35 per share.	26 Feb 2026	632,874	8,032,037	-	4.4	2,753,002	Class A Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 4.44 per share.	26 Feb 2026	632,874	2,064,911	-	4.4	2,809,961	Class A Common Stock
Alphabet (Class A)	Sundar Pichai	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	26 Feb 2026	555,732	555,732 (0%)	0%		0	Class C Capital Stock
Alphabet (Class A)	Sundar Pichai	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	26 Feb 2026	555,732	555,732 (0%)	0%		0	Class C Capital Stock
Alphabet (Class A)	Sundar Pichai	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	26 Feb 2026	555,732	0 (0%)	0%		0	Class C Capital Stock
Alphabet (Class A)	Sundar Pichai	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	26 Feb 2026	555,732	555,732 (0%)	0%		0	Class C Capital Stock
American Axle & Manufacturing Holdings Inc	David C. Dauch	Director, Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	537,667	2,470,690 (2%)	0%		0	Common Stock
Coca-Cola	James Robert Quincey	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	522,910	522,910	-		-	Employee Stock Option (Right to Buy)
Enviri Corp	F. Nicholas Grasberger	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	476,504	1,772,233 (2%)	0%		0	Common Stock
Coca-Cola	Henrique Braun	EVP & Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	453,189	453,189	-		-	Employee Stock Option (Right to Buy)
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.34 per share.	26 Feb 2026	448,712	1,255,422	-	5.3	2,396,122	Class A common stock
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	448,712	0	-		-	Employee Stock Option (right to buy)
Perimeter Soln SA	Haitham Khouri	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	400,000	1,200,000	-		-	Stock Option (right to buy)
Navitas Semiconductor Corp	Ranbir Singh	Director	Sale of securities on an exchange or to another person at price $ 9.52 per share.	26 Feb 2026	389,096	0	-	9.5	3,704,155	Class A Common Stock
Wells Fargo Rising Revenue	Charles W. Scharf	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	377,680	377,680	-		-	2023 Performance Shares
Cushman & Wakefield PLC	Michelle M. MacKay	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	370,036	370,036	-		-	Restricted Stock Units
Helix Energy Soln Grp Inc	Owen E. Kratz	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	368,292	0	-		-	Performance Share Units
Sinclair Inc (Class A)	Christopher S. Ripley	President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	360,750	975,091 (1%)	0%		-	Class A Common Stock
Unisys Corp	Debra W. McCann	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	349,795	693,661 (1%)	0%		0	Common Stock
Teva- pharma Ind Ltd (ADR)	Eli Kalif	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 33.64 per share.	26 Feb 2026	345,810	57,478 (0%)	0%	33.6	11,634,708	Ordinary Shares
Unisys Corp	Chris Arrasmith	EVP & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	339,507	514,919 (0%)	0%		0	Common Stock
SiriusPoint Ltd	David E. Govrin	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	315,738	833,713 (0%)	0%		0	Common Shares
CSX 10-year high	Stephen F. Angel	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	315,618	315,618	-		-	Option
Generate Biomedicines Inc	Gevorg Grigoryan	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	295,608	295,608	-		-	Stock Option (Right to Buy)
Generate Biomedicines Inc	Jason Silvers	President & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	295,608	295,608	-		-	Stock Option (Right to Buy)
Iridium Comm Inc	Matthew J. Desch	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	292,275	1,522,648 (1%)	0%		0	Common Stock
Avalo Therapeutics Inc	Garry A. Neil	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	286,000	286,000	-		-	Stock Option (Right to Buy)
Generate Biomedicines Inc	Jason Silvers	President & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	274,493	274,493	-		-	Stock Option (Right to Buy)
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.93 per share.	26 Feb 2026	271,525	983,897	-	14.9	4,053,868	Class A common stock
Altimmune Inc	Gregory L. Weaver	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	259,000	259,000	-		-	Stock Options (option to buy)
Unisys Corp	Kristen Prohl	SVP, GC, Secretary & CAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	257,202	444,950 (0%)	0%		0	Common Stock
Leggett & Platt Inc	Karl G. Glassman	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	256,235	1,177,313 (0%)	0%		0	Common Stock
Butterfly Network Inc (Class A)	Steve Cashman	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 4.35 per share.	26 Feb 2026	250,000	1,931,884	-	4.3	1,087,000	Class A Common Stock
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner		26 Feb 2026	250,000	250,000	-		0	Class A Common Stock
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner		26 Feb 2026	250,000	35,397,434	-		-	Class B Common Stock
The Baldwin Insurance Grp Inc (Class A)	James Roche	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	240,000	302,810 (1%)	1%		0	Class A Common Stock
Enviri Corp	F. Nicholas Grasberger	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	238,252	0	-		-	Performance Share Units
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 30.76 per share.	26 Feb 2026	237,713	12,287	-	30.8	7,312,931	Class A Common Stock
Sinclair Inc (Class A)	David D. Smith	Director, Executive Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	230,880	629,109 (0%)	0%		-	Class A Common Stock
Altimmune Inc	M. Scot Roberts	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	222,670	222,670	-		-	Stock Options (option to buy)
Enviri Corp	F. Nicholas Grasberger	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share.	26 Feb 2026	218,891	1,553,342 (1%)	0%	18.6	4,069,184	Common Stock
Arvinas Inc	Randy Teel	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	218,691	218,691	-		-	Stock Option (right to buy)
Innventure Inc	Michael Otworth	Director, Executive Chairman	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share.	26 Feb 2026	218,577	3,274,030	-	2.8	612,016	Common Stock
ACV Auctions Inc (Class A)	Michael Waterman	Chief Sales Officer	Purchase of securities on an exchange or from another person at price $ 4.66 per share.	26 Feb 2026	214,600	569,102	-	4.7	1,000,036	Common Stock
ClearSign Tech Corp	Colin James Deller	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	210,043	381,896 (1%)	0%		0	Common Stock
Perimeter Soln SA	Jeffrey Emery	President - Global Fire Safety	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	200,000	500,000	-		-	Stock Option (right to buy)
Hasbro Results Board Meeting	Christian P. Cocks	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.78 per share.	26 Feb 2026	196,411	499,721 (0%)	0%	55.8	10,955,806	Common Stock (Par Value $.50 per share)
Hasbro Results Board Meeting	Christian P. Cocks	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	196,411	0	-		-	Option (Right to Buy)
Generate Biomedicines Inc	Gevorg Grigoryan	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	196,368	196,368	-		-	Stock Option (Right to Buy)
Hasbro Results Board Meeting	Christian P. Cocks	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 100.32 per share.	26 Feb 2026	191,211	308,510 (0%)	0%	100.3	19,181,618	Common Stock (Par Value $.50 per share)
Unisys Corp	Teresa Poggenpohl	SVP & CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	185,186	332,569 (0%)	0%		0	Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	180,737	0	-		-	Restricted Stock Units
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.41 per share.	26 Feb 2026	180,737	460,726	-	4.4	797,050	Class A Common Stock
New York Times Co. (Class A)	Meredith Kopit Levien	Director, PRESIDENT & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	177,140	276,783 (0%)	0%		0	Class A Common Stock
Vaxcyte Inc	Grant E. Pickering	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	175,698	175,698	-		-	Stock Option (right to buy)
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner		26 Feb 2026	174,430	523,289	-		-	Class B Common Stock
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner		26 Feb 2026	174,430	174,430	-		0	Class A Common Stock
Interface Inc	Laurel M. Hurd	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	173,046	591,053 (1%)	0%		0	Common Stock
Shift4 Payments Inc (Class A)	Jared Isaacman	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 44.15 per share.	26 Feb 2026	159,244	1,321,207	-	44.1	7,030,416	Class A Common Stock
10x Genomics Inc (Class A)	Serge Saxonov	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	157,895	1,219,819 (5%)	0%		0	Class A Common Stock
SiriusPoint Ltd	Robin Gibbs	CEO, SiriusPoint International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	153,988	234,586 (0%)	0%		0	Common Shares
Lemaitre Vascular Inc	George W. Lemaitre	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 106.76 per share.	26 Feb 2026	150,000	1,532,304 (7%)	0%	106.8	16,013,355	Common Stock
Fold Holdings Inc (Class A) 10-year low	Jonathan Kirkwood	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	26 Feb 2026	148,000	0	-		-	7.0% Convertible Note
Arvinas Inc	Randy Teel	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	147,791	297,487 (0%)	0%		0	Common Stock
Arvinas Inc	Randy Teel	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	147,179	296,875 (0%)	0%		0	Common Stock
Sinclair Inc (Class A)	Jason Ryan Smith	Executive Vice Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	144,300	335,218 (0%)	0%		-	Class A Common Stock
Unisys Corp	Joel Raper	SVP & Chief Comm. Off	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	144,033	260,534 (0%)	0%		0	Common Stock
CompoSecure Inc (Class A)	Kurt Schoen	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	143,754	143,754	-		-	Stock Option (Right to Buy)
Tenable Holdings Inc	Matthew C. Brown	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	141,898	141,898	-		-	Restricted Stock Units
Helix Energy Soln Grp Inc	Scott A. Sparks	EVP & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	140,667	0	-		-	Performance Share Units
Veracyte Inc	Marc A. Stapley	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	139,074	458,373 (0%)	0%		0	Common Stock
Cushman & Wakefield PLC	Andrew McDonald	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	138,989	138,989	-		-	Restricted Stock Units
Corning	Wendell P. Weeks	Director, Chairman, CEO and President	Sale of securities on an exchange or to another person at price $ 155.37 per share.	26 Feb 2026	137,514	750,585 (0%)	0%	155.4	21,365,839	Common Stock
Corning	Wendell P. Weeks	Director, Chairman, CEO and President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.00 per share.	26 Feb 2026	137,514	888,099 (0%)	0%	27	3,712,878	Common Stock
Corning	Wendell P. Weeks	Director, Chairman, CEO and President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	137,514	0	-		-	Stock Options (Right to Buy)
Shift4 Payments Inc (Class A)	Jared Isaacman	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 48.38 per share.	26 Feb 2026	136,993	1,161,963	-	48.4	6,627,845	Class A Common Stock
Iridium Comm Inc	Suzanne E. McBride	Director, CHIEF OPERATIONS OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	133,611	394,639 (0%)	0%		0	Common Stock
Mereo Biopharma Grp PLC (ADR)	Anders Olof Adolf Ekblom	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	133,560	133,560	-		-	Deferred Restricted Stock Units
Helix Energy Soln Grp Inc	Erik Staffeldt	EVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	132,995	0	-		-	Performance Share Units
American Axle & Manufacturing Holdings Inc	Michael Joseph Lynch	President Driveline	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	128,509	947,398 (0%)	0%		0	Common Stock
Nu Skin Enterprises Inc (Class A)	Ryan S. Napierski	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.63 per share.	26 Feb 2026	124,802	719,552 (1%)	0%	8.6	1,077,041	Class A Common Stock
Wells Fargo Rising Revenue	Michael P. Santomassimo	Sr. EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	124,791	124,791	-		-	2023 Performance Shares
Coca-Cola	Jennifer Kay Mann	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	122,012	122,012	-		-	Employee Stock Option (Right to Buy)
Perimeter Soln SA	Noriko Yokozuka	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	120,000	360,000	-		-	Stock Option (right to buy)
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 30.30 per share.	26 Feb 2026	117,617	56,813	-	30.3	3,563,430	Class A Common Stock
Mereo Biopharma Grp PLC (ADR)	Jeremy Bender	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	117,533	117,533	-		-	Deferred Restricted Stock Units
Generate Biomedicines Inc	Beth Grous	Chief People Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	114,020	114,020	-		-	Stock Option (Right to Buy)
American Axle & Manufacturing Holdings Inc	Christopher J. May	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	113,738	1,128,706 (1%)	0%		0	Common Stock
Sinclair Inc (Class A)	Robert D. Weisbord	COO & President of Local Media	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	111,833	338,645 (0%)	0%		-	Class A Common Stock
AdvanSix Inc	Erin N. Kane	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 17.79 per share.	26 Feb 2026	111,298	656,745 (2%)	0%	17.8	1,979,991	Common Stock, par value $0.01
Altimmune Inc	Gregory L. Weaver	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	111,000	111,000	-		-	Restricted Stock Units
Mereo Biopharma Grp PLC (ADR)	Annalisa Mary Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	106,848	106,848	-		-	Deferred Restricted Stock Units
Mereo Biopharma Grp PLC (ADR)	Pierre Jacquet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	106,848	106,848	-		-	Deferred Restricted Stock Units
10x Genomics Inc (Class A)	Adam S. Taich	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	106,579	394,996 (1%)	0%		0	Class A Common Stock
Vaxcyte Inc	Grant E. Pickering	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	105,110	506,018	-		0	Common Stock
ClearSign Tech Corp	Colin James Deller	Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.56 per share.	26 Feb 2026	105,022	276,874 (1%)	0%	0.6	58,980	Common Stock
Silgan Holdings Inc	Adam J. Greenlee	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	105,000	433,164 (0%)	0%		-	Common Stock
Avalo Therapeutics Inc	Christopher Ryan Sullivan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	105,000	105,000	-		-	Stock Option (Right to Buy)
Avalo Therapeutics Inc	Mittie Doyle	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	105,000	105,000	-		-	Stock Option (Right to Buy)
Sinclair Inc (Class A)	David D. Smith	Director, Executive Chairman, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.86 per share.	26 Feb 2026	102,536	526,573 (0%)	0%	13.9	1,421,149	Class A Common Stock
Cushman & Wakefield PLC	Michelle M. MacKay	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	101,540	203,082	-		-	Restricted Stock Units
Cushman & Wakefield PLC	Michelle M. MacKay	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	101,540	471,256 (0%)	0%		0	Common Shares
Wells Fargo Rising Revenue	Barry Sommers	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	100,480	100,480	-		-	2023 Performance Shares
Delta Air Lines	Edward H. Bastian	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 70.26 per share.	26 Feb 2026	100,000	1,363,448 (0%)	0%	70.3	7,025,700	Common Stock
Eastman Kodak Co.	James V. Continenza	Director, Executive Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	100,000	3,150,896 (7%)	0%		0	Common Stock, par value $.01
Eastman Kodak Co.	James V. Continenza	Director, Executive Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	100,000	0	-		-	Restricted Stock Units
Perimeter Soln SA	Haitham Khouri	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	100,000	200,000	-		-	Stock Option (right to buy)
Perimeter Soln SA	Kyle Sable	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	100,000	300,000	-		-	Stock Option (right to buy)
Perimeter Soln SA	Grant Bowman	President, Specialty Products	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	100,000	200,000	-		-	Stock Option (right to buy)
Wells Fargo Rising Revenue	Scott E. Powell	SEVP & Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	98,136	98,136	-		-	2023 Performance Shares
Axogen Inc	Michael J. Dale	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	98,000	98,000	-		-	Restricted Stock Units
Helix Energy Soln Grp Inc	Kenneth E. Neikirk	EVP, GEN COUNSEL & SECRETARY	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	97,188	0	-		-	Performance Share Units
Wells Fargo Rising Revenue	Ellen R. Patterson	Sr. EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	96,724	96,724	-		-	2023 Performance Shares
Mereo Biopharma Grp PLC (ADR)	Marc J. Yoskowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	96,163	96,163	-		-	Deferred Restricted Stock Units
Mereo Biopharma Grp PLC (ADR)	Daniel Shames	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	96,163	96,163	-		-	Deferred Restricted Stock Units
Iridium Comm Inc	Matthew J. Desch	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	95,893	1,230,373 (0%)	0%		0	Common Stock
Altimmune Inc	M. Scot Roberts	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	95,430	95,430	-		-	Restricted Stock Units
Avalo Therapeutics Inc	Jennifer Riley	Chief Strategy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	95,000	95,000	-		-	Stock Option (Right to Buy)
Avalo Therapeutics Inc	Taylor Boyd	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	95,000	95,000	-		-	Stock Option (Right to Buy)
New York Times Co. (Class A)	A. G. Sulzberger	Director, Chairman and Publisher	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	93,724	237,168 (0%)	0%		0	Class A Common Stock
AXT Inc	Gary L. Fischer	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	92,440	0	-		-	Stock Option (Right to Buy)
AXT Inc	Gary L. Fischer	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.06 per share.	26 Feb 2026	92,440	685,543 (1%)	0%	3.1	282,866	Common Stock
SiriusPoint Ltd	Thomas C. Leonardo	Global Head of A&H	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	91,410	252,742 (0%)	0%		0	Common Shares
New York Times Co. (Class A)	Meredith Kopit Levien	Director, PRESIDENT & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.38 per share.	26 Feb 2026	90,431	186,352 (0%)	0%	77.4	6,997,551	Class A Common Stock
IBM Industry Headwinds	Arvind Krishna	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	90,071	90,071	-		-	Emp. Stock Option (right to buy)
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	89,742	270,355	-		0	Class B common stock
10x Genomics Inc (Class A)	Benjamin J. Hindson	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	88,816	513,595 (2%)	0%		0	Class A Common Stock
Perimeter Soln SA	Haitham Khouri	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	88,489	88,489	-		-	Stock Option (right to buy)
Wells Fargo Rising Revenue	Saul Van Beurden	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	87,691	87,691	-		-	2023 Performance Shares
Bancfirst Corp Results	Tom H. Mccasland	Director	Other type of transaction at price $ 0.00 per share.	26 Feb 2026	85,006	0 (0%)	0%		0	Common Stock
Clearwater Paper Corp	Arsen S. Kitch	President, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	83,623	407,398 (2%)	0%		0	Common Stock
Iridium Comm Inc	Vincent J. O’Neill	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	83,507	136,036 (0%)	0%		0	Common Stock
American Axle & Manufacturing Holdings Inc	Markus Bannert	President - Metal Forming	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	83,267	320,184 (0%)	0%		0	Common Stock
New York Times Co. (Class A)	Meredith Kopit Levien	Director, PRESIDENT & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	82,505	285,358 (0%)	0%		0	Class A Common Stock
Quanta Services	Earl C. Austin	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	81,834	739,304 (0%)	0%		0	Common Stock
Coca-Cola	Manuel Arroyo	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	81,358	81,358	-		-	Employee Stock Option (Right to Buy)
Avalo Therapeutics Inc	Paul Varki	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	80,000	80,000	-		-	Stock Option (Right to Buy)
American Axle & Manufacturing Holdings Inc	Terri M. Kemp	SVP - Chief of Staff	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	79,764	460,271 (0%)	0%		0	Common Stock
American Axle & Manufacturing Holdings Inc	Tolga I. Tolga	President Driveline	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	79,764	334,695 (0%)	0%		0	Common Stock
Cushman & Wakefield PLC	Neil O. Johnston	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	79,423	79,423	-		-	Restricted Stock Units
Brown & Brown	J. Powell Brown	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	78,030	186,193 (0%)	0%		0	Common Stock, $.10 par value (2019 SIP)
Unisys Corp	Shalabh Gupta	VP & Corporate Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	77,161	202,479 (0%)	0%		0	Common Stock
Unisys Corp	David Brown	VP, CAO, Corporate Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	77,161	121,877 (0%)	0%		0	Common Stock
Interface Inc	Laurel M. Hurd	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.79 per share.	26 Feb 2026	77,075	513,978 (0%)	0%	31.8	2,450,214	Common Stock
Coca-Cola	Nancy Quan	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	76,694	76,694	-		-	Employee Stock Option (Right to Buy)
CSX 10-year high	Kevin S. Boone	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	75,982	75,982	-		-	Option
CSX 10-year high	Michael A Cory	EVP & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	75,982	75,982	-		-	Option
Sinclair Inc (Class A)	David B. Gibber	EVP & Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	75,758	241,030 (0%)	0%		-	Class A Common Stock
ANI Pharma Inc	Nikhil Lalwani	Director, PRESIDENT & CEO	Grant, award, or other acquisition of securities at price $ 77.15 per share.	26 Feb 2026	75,592	434,166 (3%)	0%	77.2	5,831,923	Common Stock
Vaxcyte Inc	Andrew L. Guggenhime	PRESIDENT AND CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	74,993	74,993	-		-	Stock Option (right to buy)
Enviri Corp	Russell C. Hochman	President & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	74,094	232,378 (0%)	0%		0	Common Stock
Somnigroup Intl Inc	Scott L. Thompson	Director, CEO & PRESIDENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	72,120	72,120	-		-	Performance Restricted Stock Units
Veracyte Inc	Phillip G. Febbo	Chief Scientific & Med Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	71,806	161,292 (0%)	0%		0	Common Stock
Iridium Comm Inc	Kathleen A. Morgan	CHIEF LEGAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	70,981	173,617 (0%)	0%		0	Common Stock
Altria Group	William F. Gifford	Director, Chief Executive Officer		26 Feb 2026	70,364	743,791 (0%)	0%		0	Common Stock
Arvinas Inc	Andrew R. Saik	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	67,000	67,000	-		-	Stock Option (right to buy)
Arvinas Inc	Angela Cacace	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	67,000	67,000	-		-	Stock Option (right to buy)
Arvinas Inc	Noah Berkowitz	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	67,000	67,000	-		-	Stock Option (right to buy)
Iridium Comm Inc	Scott T. Scheimreif	EVP-GOVERNMENT PROGRAMS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,805	276,953 (0%)	0%		0	Common Stock
Iridium Comm Inc	Timothy Last	EVP, Sales & Marketing	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,805	120,650 (0%)	0%		0	Common Stock
Federal Signal Corp	Jennifer L. Sherman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,508	636,672 (1%)	0%		0	Common Stock
Wells Fargo Rising Revenue	Derek A. Flowers	Sr. EVP and Chief Risk Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,088	66,088	-		-	2023 Performance Shares
SiriusPoint Ltd	Thomas C. Leonardo	Global Head of A&H	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,076	318,818 (0%)	0%		0	Common Shares
Mereo Biopharma Grp PLC (ADR)	Michael Stephen Wyzga	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,000	66,000	-		-	Share Options (Right to buy)
Mereo Biopharma Grp PLC (ADR)	Deepika Rachel Pakianathan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,000	66,000	-		-	Share Options (Right to buy)
Mereo Biopharma Grp PLC (ADR)	Anders Olof Adolf Ekblom	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,000	66,000	-		-	Share Options (Right to buy)
Mereo Biopharma Grp PLC (ADR)	Marc J. Yoskowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,000	66,000	-		-	Share Options (Right to buy)
Mereo Biopharma Grp PLC (ADR)	Annalisa Mary Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,000	66,000	-		-	Share Options (Right to buy)
Mereo Biopharma Grp PLC (ADR)	Pierre Jacquet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,000	66,000	-		-	Share Options (Right to buy)
Mereo Biopharma Grp PLC (ADR)	Jeremy Bender	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,000	66,000	-		-	Share Options (Right to buy)
Mereo Biopharma Grp PLC (ADR)	Daniel Shames	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	66,000	66,000	-		-	Share Options (Right to buy)
AXT Inc	Gary L. Fischer	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.21 per share.	26 Feb 2026	65,685	503,400 (1%)	0%	5.2	342,219	Common Stock
AXT Inc	Gary L. Fischer	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	65,685	0	-		-	Stock Option (Right to Buy)
Ovid Therapeutics Inc	Bart Friedman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	65,000	65,000	-		-	Employee Stock Option (Right to Buy)
Ovid Therapeutics Inc	Stelios Papadopoulos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	65,000	65,000	-		-	Employee Stock Option (Right to Buy)
Ovid Therapeutics Inc	Barbara G. Duncan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	65,000	65,000	-		-	Employee Stock Option (Right to Buy)
Ovid Therapeutics Inc	Karen Bernstein	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	65,000	65,000	-		-	Employee Stock Option (Right to Buy)
Ovid Therapeutics Inc	Kevin Joseph Fitzgerald	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	65,000	65,000	-		-	Employee Stock Option (Right to Buy)
Appian Corp (Class A)	Matthew W. Calkins	Director, CEO and President, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	64,375	64,375	-		-	Restricted Stock Unit
CSX 10-year high	Stephen F. Angel	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	63,306	121,540 (0%)	0%		0	Common Stock
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner		26 Feb 2026	62,500	14,754,517	-		-	Class B Common Stock
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner		26 Feb 2026	62,500	62,500	-		0	Class A Common Stock
Altria Group	William F. Gifford	Director, Chief Executive Officer		26 Feb 2026	61,849	681,942 (0%)	0%	69.7	4,310,875	Common Stock
Wells Fargo Rising Revenue	Kleber R. Santos	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	60,579	60,579	-		-	2023 Performance Shares
Wells Fargo Rising Revenue	Ellen R. Patterson	Sr. EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 87.40 per share.	26 Feb 2026	60,000	169,496 (0%)	0%	87.4	5,244,000	Common Stock, $1 2/3 Par Value
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 30.76 per share.	26 Feb 2026	59,430	3,070	-	30.8	1,828,287	Class A Common Stock
Veracyte Inc	Rebecca Chambers	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	59,324	168,820 (0%)	0%		0	Common Stock
Enviri Corp	Jeffrey A. Beswick	SVP & Grp. Pres., Clean Earth	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	58,674	125,701 (0%)	0%		0	Common Stock
Talen Energy Corp - Ordinary Shares New	Mark A. McFarland	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	58,420	58,420	-		-	2026 Performance-Based Restricted Stock Units
Wells Fargo Rising Revenue	Kyle G. Hranicky	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	57,821	57,821	-		-	2023 Performance Shares
Mannkind Corp	Michael E. Castagna	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	57,750	57,750	-		-	Employee Stock Option (right to buy)
Standard BioTools Inc	Troy M. Cox	Director	Grant, award, or other acquisition of securities at price $ 1.17 per share.	26 Feb 2026	57,264	376,586 (0%)	0%	1.2	66,999	Common Stock
ClearSign Tech Corp	Brent Hinds	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	56,645	191,585 (0%)	0%		0	Common Stock
Cushman & Wakefield PLC	Michelle M. MacKay	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.41 per share.	26 Feb 2026	56,152	415,104 (0%)	0%	13.4	752,998	Common Shares
Lemaitre Vascular Inc	George W. Lemaitre	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 107.81 per share.	26 Feb 2026	55,930	1,476,500 (7%)	0%	107.8	6,030,020	Common Stock
AXT Inc	Gary L. Fischer	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	55,500	0	-		-	Stock Option (Right to Buy)
AXT Inc	Gary L. Fischer	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.77 per share.	26 Feb 2026	55,500	593,103 (1%)	0%	5.8	320,235	Common Stock
Interface Inc	Bruce Andrew Hausmann	VP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	55,198	204,304 (0%)	0%		0	Common Stock
Seaport Entertainment Grp Inc	Matthew M. Partridge	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	55,148	55,148	-		-	Non-Qualified Stock Option (Right to Buy)
Euronet Worldwide Inc	Michael J. Brown	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	54,949	1,475,133 (2%)	0%		0	Common Stock, par value $0.02 per share
Adma Biologics Inc	Adam S. Grossman	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.18 per share.	26 Feb 2026	54,858	2,204,728 (2%)	0%	15.2	832,744	Common Stock
Axsome Therapeutics Inc	Herriot Tabuteau	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	54,623	54,623	-		-	Restricted Stock Units
Five9 Inc	Michael Burkland	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.13 per share.	26 Feb 2026	54,375	403,945 (0%)	0%	8.1	442,069	Common Stock
Five9 Inc	Michael Burkland	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	54,375	0	-		-	Employee Stock Option (right to buy)
CSX 10-year high	Stephen Fortune	EVP - CD & TO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	54,357	54,357	-		-	Option
Cushman & Wakefield PLC	Andrew McDonald	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	53,921	107,844	-		-	Restricted Stock Units
Cushman & Wakefield PLC	Andrew McDonald	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	53,921	477,805 (0%)	0%		0	Common Shares
Vaxcyte Inc	Jim Wassil	CHIEF OPERATING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	53,566	53,566	-		-	Stock Option (right to buy)
Coca-Cola	Bruno Pietracci	President, Latin America OU	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	53,464	53,464	-		-	Employee Stock Option (Right to Buy)
Coca-Cola	Luisa Ortega	Europe OU President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	53,464	53,464	-		-	Employee Stock Option (Right to Buy)
Vaxcyte Inc	Harp Dhaliwal	Chief Technical Ops Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	53,409	77,337	-		0	Common Stock
Iridium Comm Inc	Matthew J. Desch	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.49 per share.	26 Feb 2026	53,301	1,469,347 (1%)	0%	22.5	1,198,739	Common Stock
Standard BioTools Inc	Eli D. Casdin	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 1.17 per share.	26 Feb 2026	52,991	2,954,053 (4%)	0%	1.2	61,999	Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.41 per share.	26 Feb 2026	52,595	408,131	-	4.4	231,944	Class A Common Stock
Exelixis Inc	Christopher J. Senner	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	52,018	1,028,110 (0%)	0%		0	Common Stock
Exelixis Inc	Dana T. Aftab	EVP, Research and Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	52,018	668,124 (0%)	0%		0	Common Stock
New York Times Co. (Class A)	A. G. Sulzberger	Director, Chairman and Publisher	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.38 per share.	26 Feb 2026	51,830	185,338 (0%)	0%	77.4	4,010,605	Class A Common Stock
Bausch + Lomb Corp	Sam A. Eldessouky	EVP and CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.30 per share.	26 Feb 2026	51,470	399,130	-	18.3	941,901	Common Shares, No Par Value
Coeur Mining Inc	Mitchell J. Krebs	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.56 per share.	26 Feb 2026	51,406	2,191,945 (0%)	0%	26.6	1,365,343	Common Stock, par value $0.01 per share
Veracyte Inc	Annie McGuire	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	50,999	119,133 (0%)	0%		0	Common Stock
Taiwan Fund Inc	William C. Kirby	Director	Purchase of securities on an exchange or from another person at price $ 64.90 per share.	26 Feb 2026	50,686	2,886 (0%)	0%	64.9	3,289,580	Taiwan Fund, Inc.
Axogen Inc	Jens Kemp	Chief Marketing Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	50,670	94,817 (0%)	0%		0	Common Stock
Koppers Holdings Inc	Leroy M. Ball	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	50,025	477,569 (2%)	0%		0	Common Stock
WPP PLC. (ADR)	Cindy Helen Rose	Executive Director,Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 2.69 per share.	26 Feb 2026	50,000	154,480 (0%)	0%	2.7	134,558	Ords 0.10p
WPP PLC. (ADR)	Philip Eric Rene Jansen	Non-Executive Director,Chairman	Purchase of securities on an exchange or from another person at price $ 2.55 per share.	26 Feb 2026	50,000	100,000 (0%)	0%	2.6	127,535	Ords 0.10p
Teradata Corp	Steve McMillan	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 30.26 per share.	26 Feb 2026	50,000	663,190 (0%)	0%	30.3	1,513,125	Common Stock
Mannkind Corp	Michael E. Castagna	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	50,000	50,000	-		-	Employee Stock Option (right to buy)
Perimeter Soln SA	Kyle Sable	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	50,000	100,000	-		-	Stock Option (right to buy)
Interface Inc	James Poppens	Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	49,678	175,388 (0%)	0%		0	Common Stock
L3Harris Tech Contract Win	Christopher E. Kubasik	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	48,882	48,882	-		-	Non-Qualified Stock Option (Right to Buy)
L3Harris Tech Contract Win	Christopher E. Kubasik	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	48,245	210,822 (0%)	0%		0	Common Stock, Par Value $1.00
Silgan Holdings Inc	Philippe Chevrier	EVP & Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	48,000	90,000 (0%)	0%		-	Common Stock
Circle Internet Grp Inc (Class A)	Jeremy Fox-Geen	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 90.00 per share.	26 Feb 2026	47,908	261,059	-	90	4,311,720	Class A Common Stock
Wells Fargo Rising Revenue	Bei Ling	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	47,218	47,218	-		-	2023 Performance Shares
Veracyte Inc	John Leite	Chief Commercial Officer-CLIA	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	47,149	129,262 (0%)	0%		0	Common Stock
ClearSign Tech Corp	Brent Hinds	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	47,009	47,009	-		-	Restricted Stock Unit
CSX 10-year high	Maryclare T. Kenney	SVP & CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	46,759	46,759	-		-	Option
SharkNinja Inc	Mark Barrocas	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 129.00 per share.	26 Feb 2026	46,511	2,161,654	-	129	5,999,919	Ordinary Shares
Vaxcyte Inc	Harp Dhaliwal	Chief Technical Ops Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	46,424	46,424	-		-	Stock Option (right to buy)
Enviri Corp	Jennifer O. Kozak	Senior Vice President & CHRO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	45,862	93,970 (0%)	0%		0	Common Stock
Cactus Inc (Class A)	Scott Bender	Director, Chairman and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	45,826	124,834 (0%)	0%		-	Class A Common Stock
Cactus Inc (Class A)	Joel Bender	Director, President, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	45,826	45,826 (0%)	0%		-	Class A Common Stock
Nu Skin Enterprises Inc (Class A)	Chayce D. Clark	EVP and General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.63 per share.	26 Feb 2026	45,502	251,775 (0%)	0%	8.6	392,682	Class A Common Stock
Mannkind Corp	Steven B. Binder	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	45,025	45,025	-		-	Employee Stock Option (right to buy)
Arvinas Inc	Andrew R. Saik	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	45,000	204,267 (0%)	0%		0	Common Stock
Arvinas Inc	Angela Cacace	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	45,000	192,623 (0%)	0%		0	Common Stock
Arvinas Inc	Noah Berkowitz	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	45,000	208,938 (0%)	0%		0	Common Stock
Vaxcyte Inc	Andrew L. Guggenhime	PRESIDENT AND CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	44,864	107,323	-		0	Common Stock
Jazz Pharma PLC	Renee D. Gala	President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	44,465	159,695 (0%)	0%		0	Ordinary Shares
Sinclair Inc (Class A)	Robert D. Weisbord	COO & President of Local Media	Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.86 per share.	26 Feb 2026	44,120	294,525 (0%)	0%	13.9	611,503	Class A Common Stock
Cable One Inc	James A. Holanda	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	44,004	44,004	-		-	RSUs
State Street Estimates Beat	Ronald P. O'Hanley	Director, Chairman, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	43,873	299,172 (0%)	0%		0	Common Stock
Genworth Fin Inc (Class A)	Jerome T. Upton	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	43,431	498,204 (0%)	0%		-	Common Stock
Genworth Fin Inc (Class A)	Jerome T. Upton	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	43,431	43,431	-		-	Restricted Stock Units
Genworth Fin Inc (Class A)	Samir B. Shah	Pres. & CEO, CareScout Svcs.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	43,431	43,431	-		-	Restricted Stock Units (RSUs)
Genworth Fin Inc (Class A)	Samir B. Shah	Pres. & CEO, CareScout Svcs.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	43,431	89,889 (0%)	0%		-	Common Stock
Criteo S.A (ADR)	Michael Komasinski	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	42,771	219,406 (0%)	0%		0	Ordinary Shares
IBM Industry Headwinds	Gary D. Cohn	Vice Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	42,258	42,258	-		-	Emp. Stock Option (right to buy)
IBM Industry Headwinds	Robert David Thomas	Senior Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	42,258	42,258	-		-	Emp. Stock Option (right to buy)
Leggett & Platt Inc	J. Tyson Hagale	EVP, Pres. - Bedding Products	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	42,253	190,046 (0%)	0%		0	Common Stock
Leggett & Platt Inc	Benjamin M. Burns	Executive Vice President - CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	42,253	189,675 (0%)	0%		0	Common Stock
Generate Biomedicines Inc	Laurie Lee	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	42,230	42,230	-		-	Stock Option (Right to Buy)
IBM Industry Headwinds	James J. Kavanaugh	Sr. VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	41,455	41,455	-		-	Emp. Stock Option (right to buy)
CSX 10-year high	Michael S. Burns	SVP - CLO & Corp Secy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	40,914	40,914	-		-	Option
ESAB Corp	Shyam P. Kambeyanda	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	40,501	40,501	-		-	Employee Stock Option (right to buy)
Exelixis Inc	Patrick J. Haley	EVP, Commercial	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	40,459	422,367 (0%)	0%		0	Common Stock
Perimeter Soln SA	Grant Bowman	President, Specialty Products	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	39,820	39,820	-		-	Stock Option (right to buy)
Cushman & Wakefield PLC	Noelle Perkins	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	39,711	39,711	-		-	Restricted Stock Units
Coca-Cola	Lisa V. Chang	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	39,517	39,517	-		-	Employee Stock Option (Right to Buy)
Eastman Kodak Co.	James V. Continenza	Director, Executive Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.53 per share.	26 Feb 2026	39,350	3,111,546 (7%)	0%	7.5	296,306	Common Stock, par value $.01
GCM Grosvenor Inc (Class A)	Angela Blanton	Director	Sale of securities on an exchange or to another person at price $ 11.88 per share.	26 Feb 2026	39,278	47,605	-	11.9	466,458	Class A Common Stock
FS Credit Opportunities Corp	Michael C. Forman	Director, See Remarks	Purchase of securities on an exchange or from another person at price $ 5.20 per share.	26 Feb 2026	38,462	38,462	-	5.2	200,002	Common Stock
New York Times Co. (Class A)	Diane Brayton	EVP, CHIEF LEGAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	38,084	64,665 (0%)	0%		0	Class A Common Stock
Interface Inc	David B. Foshee	Vice President/Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	37,595	243,368 (0%)	0%		0	Common Stock
Mannkind Corp	David B. Thomson	EVP Genl Counsel & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	37,525	37,525	-		-	Employee Stock Option (right to buy)
Mannkind Corp	Michael E. Castagna	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	37,525	37,525	-		-	Employee Stock Option (right to buy)
Genworth Fin Inc (Class A)	Jerome T. Upton	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	37,506	524,162 (0%)	0%		-	Common Stock
Genworth Fin Inc (Class A)	Jerome T. Upton	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	37,506	75,012	-		-	Restricted Stock Units
Genworth Fin Inc (Class A)	Samir B. Shah	Pres. & CEO, CareScout Svcs.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	37,506	75,012	-		-	Restricted Stock Units
Genworth Fin Inc (Class A)	Samir B. Shah	Pres. & CEO, CareScout Svcs.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	37,506	111,712 (0%)	0%		-	Common Stock
Enviri Corp	Russell C. Hochman	President & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	37,047	0	-		-	Performance Share Units
Cushman & Wakefield PLC	Nathaniel Robinson	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	36,101	36,101	-		-	Restricted Stock Units
Veracyte Inc	Marc A. Stapley	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.75 per share.	26 Feb 2026	35,841	422,532 (0%)	0%	38.8	1,388,839	Common Stock
Federal Signal Corp	Jennifer L. Sherman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	35,742	35,742	-		-	Stock Option (right to buy)
Axsome Therapeutics Inc	Mark Jacobson	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.85 per share.	26 Feb 2026	35,378	35,378 (0%)	0%	2.8	100,827	Common Stock
Axsome Therapeutics Inc	Mark Jacobson	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 161.88 per share.	26 Feb 2026	35,378	0 (0%)	0%	161.9	5,726,991	Common Stock
Axsome Therapeutics Inc	Mark Jacobson	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	35,378	0	-		-	Stock Option (Right to Buy)
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.81 per share.	26 Feb 2026	35,313	235,042	-	12.8	452,360	Class B common stock
Flutter Entertainment PLC	Daniel Mark Taylor	CEO - Flutter International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	34,878	34,878	-		-	Nil Cost Options (Right to Buy)
Enviri Corp	Russell C. Hochman	President & COO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share.	26 Feb 2026	34,547	197,831 (0%)	0%	18.6	642,229	Common Stock
Iridium Comm Inc	Thomas J. Fitzpatrick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	34,247	276,161 (0%)	0%		0	Common Stock
Iridium Comm Inc	Suzanne E. McBride	Director, CHIEF OPERATIONS OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	34,247	261,028 (0%)	0%		0	Common Stock
AXT Inc	Gary L. Fischer	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	34,203	0	-		-	Stock Option (Right to Buy)
AXT Inc	Gary L. Fischer	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.50 per share.	26 Feb 2026	34,203	537,603 (1%)	0%	9.5	324,929	Common Stock
Avalonbay Communities Analyst Downgrade	Benjamin W. Schall	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	33,996	118,680 (0%)	0%		0	Common Stock, par value $.01 per share
Axogen Inc	Erick Wayne DeVinney	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	33,780	274,912 (0%)	0%		0	Common Stock
Axogen Inc	Marc A. Began	EVP & General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	33,780	52,065 (0%)	0%		0	Common Stock
Figma Inc Ordinary Shares	Dylan Field	Director, President & CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 31.44 per share.	26 Feb 2026	33,177	23,636	-	31.4	1,042,942	Class A Common Stock
Talen Energy Corp - Ordinary Shares New	Terry L. Nutt	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	33,086	33,086	-		-	2026 Performance-Based Restricted Stock Units
Navitas Semiconductor Corp	Todd Glickman	Sr. V.P., CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	32,636	845,915	-		0	Class A Common Stock
Quanta Services	Earl C. Austin	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 562.77 per share.	26 Feb 2026	32,202	707,102 (0%)	0%	562.8	18,122,320	Common Stock
Vaxcyte Inc	Jim Wassil	CHIEF OPERATING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	32,045	173,893	-		0	Common Stock
Cava Grp Inc	Kelly Costanza	Chief People Officer	Sale of securities on an exchange or to another person at price $ 84.45 per share.	26 Feb 2026	31,803	123,860	-	84.4	2,685,763	Common Stock
Cava Grp Inc	Kelly Costanza	Chief People Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.75 per share.	26 Feb 2026	31,803	155,663	-	6.7	214,670	Common Stock
Cava Grp Inc	Kelly Costanza	Chief People Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	31,803	0	-		-	Stock Options (right to buy)
New York Times Co. (Class A)	William Bardeen	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	31,668	42,000 (0%)	0%		0	Class A Common Stock
WSFS Fin Corp 10-year high	Rodger Levenson	President & CEO	Grant, award, or other acquisition of securities at price $ 66.38 per share.	26 Feb 2026	31,245	194,528 (0%)	0%	66.4	2,074,043	Common Stock
Henry Schein	Stanley M. Bergman	Director, Chairman, CEO	Sale of securities on an exchange or to another person at price $ 80.90 per share.	26 Feb 2026	31,134	434,827 (0%)	0%	80.9	2,518,741	Common Stock par value $0.01 per share
Cushman & Wakefield PLC	Neil O. Johnston	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,812	61,625	-		-	Restricted Stock Units
Cushman & Wakefield PLC	Neil O. Johnston	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,812	330,741 (0%)	0%		0	Common Shares
Leggett & Platt Inc	Jennifer Joy Davis	EVP - GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	30,809	117,578 (0%)	0%		0	Common Stock
Fold Holdings Inc (Class A) 10-year low	Wolfe Repass	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,785	34,304	-		-	Restricted Stock Units
Fold Holdings Inc (Class A) 10-year low	Wolfe Repass	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,785	249,339	-		-	Common Stock
Fold Holdings Inc (Class A) 10-year low	Wolfe Repass	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,785	227,731	-		-	Common Stock
Fold Holdings Inc (Class A) 10-year low	Wolfe Repass	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,785	65,089	-		-	Restricted Stock Units
Duke Energy	Harry K. Sideris	Director, President, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	30,540	121,760 (0%)	0%		0	Common Stock
Amgen	Esteban Santos	EVP, Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,501	0	-		-	Nqso (Right to Buy)
Amgen	Esteban Santos	EVP, Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 162.60 per share.	26 Feb 2026	30,501	107,119 (0%)	0%	162.6	4,959,463	Common Stock
Amgen	Esteban Santos	EVP, Operations	Sale of securities on an exchange or to another person at price $ 379.12 per share.	26 Feb 2026	30,501	76,618 (0%)	0%	379.1	11,563,457	Common Stock
Cannae Holdings Inc	Ryan R. Caswell	CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	26 Feb 2026	30,325	269,675	-		0	Restricted Stock Units
Cannae Holdings Inc	Ryan R. Caswell	CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	30,325	327,496 (0%)	0%		0	Common Stock
Cannae Holdings Inc	Ryan R. Caswell	CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	30,325	297,171 (0%)	0%		0	Common Stock
Cannae Holdings Inc	Ryan R. Caswell	CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	26 Feb 2026	30,325	300,000	-		0	Restricted Stock Units
Genworth Fin Inc (Class A)	Jamala M. Arland	Pres. & CEO, U.S. Life Ins.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,004	96,987 (0%)	0%		-	Common Stock
Genworth Fin Inc (Class A)	Jamala M. Arland	Pres. & CEO, U.S. Life Ins.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,004	60,010	-		-	Restricted Stock Units
Wells Fargo Rising Revenue	Bridget E. Engle	Sr. Executive Vice President	Sale of securities on an exchange or to another person at price $ 87.10 per share.	26 Feb 2026	30,000	83,478 (0%)	0%	87.1	2,613,000	Common Stock, $1 2/3 Par Value
Circle Internet Grp Inc (Class A)	P. Sean Neville	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,000	1,999,073	-		-	Stock Option (Right to Buy)
Circle Internet Grp Inc (Class A)	P. Sean Neville	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	30,000	2,396,356	-		-	Class B Common Stock
Circle Internet Grp Inc (Class A)	P. Sean Neville	Director		26 Feb 2026	30,000	2,366,356	-		-	Class B Common Stock
Circle Internet Grp Inc (Class A)	P. Sean Neville	Director		26 Feb 2026	30,000	30,000	-		-	Class A Common Stock
Circle Internet Grp Inc (Class A)	P. Sean Neville	Director	Sale of securities on an exchange or to another person at price $ 90.00 per share.	26 Feb 2026	30,000	0	-	90	2,700,000	Class A Common Stock
Edesa Biotech Inc	Pardeep Nijhawan	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 2.22 per share.	26 Feb 2026	30,000	371,702 (4%)	0%	2.2	66,696	Common Shares
Ensign Grp Inc	Barry R. Port	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	30,000	30,000	-		-	Employee Stock Option (right to buy)
Generate Biomedicines Inc	Rupert Vessey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	29,561	29,561	-		-	Stock Option (Right to Buy)
Federal Signal Corp	Jennifer L. Sherman	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.63 per share.	26 Feb 2026	29,455	607,217 (1%)	0%	117.6	3,464,792	Common Stock
Enviri Corp	Jeffrey A. Beswick	SVP & Grp. Pres., Clean Earth	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	29,337	0	-		-	Performance Share Units
Genworth Fin Inc (Class A)	Kelly A. Saltzgaber	EVP & Chief Investment Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	29,316	97,588 (0%)	0%		-	Common Stock
Genworth Fin Inc (Class A)	Kelly A. Saltzgaber	EVP & Chief Investment Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	29,316	29,316	-		-	Restricted Stock Units
Cava Grp Inc	Brett Schulman	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	29,060	831,843	-		0	Common Stock
MBX Biosciences Inc	Peter Kent Hawryluk	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share.	26 Feb 2026	28,768	728,274	-	16	460,288	Common Stock
MBX Biosciences Inc	Peter Kent Hawryluk	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	28,768	91,668	-		-	Stock option (right to buy)
Nu Skin Enterprises Inc (Class A)	James D. Thomas	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.63 per share.	26 Feb 2026	28,602	152,396 (0%)	0%	8.6	246,835	Class A Common Stock
Inovio Pharma Inc	Jacqueline E. Shea	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	28,401	56,800	-		-	Restricted Stock Unit
Inovio Pharma Inc	Jacqueline E. Shea	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	28,401	98,661 (0%)	0%		-	Common Stock
Arthur J. Gallagher	Thomas Joseph Gallagher	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	28,200	0	-		-	Non-qualified Stock Option
Arthur J. Gallagher	Thomas Joseph Gallagher	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.59 per share.	26 Feb 2026	28,200	318,691 (0%)	0%	75.6	2,131,638	Common Stock
Merit Medical Systems Inc	Martha Goldberg Aronson	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	28,198	47,792 (0%)	0%		0	Common Stock, No Par Value
Estee Lauder (Class A)	Hendrik Rene Lammers	EVP & CR&IO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	28,156	28,156	-		-	Option (Right to Buy)
Mannkind Corp	Stuart A. Tross	Chief People & Workpl Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	28,143	28,143	-		-	Employee Stock Option (right to buy)
Genworth Fin Inc (Class A)	Kelly A. Saltzgaber	EVP & Chief Investment Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	28,129	117,218 (0%)	0%		-	Common Stock
Genworth Fin Inc (Class A)	Kelly A. Saltzgaber	EVP & Chief Investment Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	28,129	56,259	-		-	Restricted Stock Units
AdvanSix Inc	Achilles B. Kintiroglou	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 17.79 per share.	26 Feb 2026	28,106	58,371 (0%)	0%	17.8	500,006	Common Stock, par value $0.01
Seaport Entertainment Grp Inc	Matthew M. Partridge	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	27,625	123,259	-		0	Common Stock
Cactus Inc (Class A)	Steven Bender	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	27,496	101,826 (0%)	0%		-	Class A Common Stock
Cactus Inc (Class A)	Stephen Tadlock	EVP/CEO Spool Tech/Cactus Intl	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	27,496	82,594 (0%)	0%		-	Class A Common Stock
Cushman & Wakefield PLC	Andrew McDonald	See Remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.41 per share.	26 Feb 2026	27,436	450,369 (0%)	0%	13.4	367,917	Common Shares
Netstreit Corp	Mark L. Manheimer	Director, President, CEO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	27,394	375,448	-		-	Common Stock
Netstreit Corp	Mark L. Manheimer	Director, President, CEO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	27,394	198,442	-		-	Restricted Stock Units
Vertiv Holdings Co (Class A)	Roger B. Fradin	Director	Sale of securities on an exchange or to another person at price $ 252.61 per share.	26 Feb 2026	27,354	81,812 (0%)	0%	252.6	6,909,894	Class A Common Stock
Genworth Fin Inc (Class A)	Gregory S. Karawan	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	27,144	344,960 (0%)	0%		-	Common Stock
Genworth Fin Inc (Class A)	Gregory S. Karawan	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	27,144	27,145	-		-	Restricted Stock Units
Genworth Fin Inc (Class A)	Jamala M. Arland	Pres. & CEO, U.S. Life Ins.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	27,144	27,145	-		-	Restricted Stock Units
Genworth Fin Inc (Class A)	Jamala M. Arland	Pres. & CEO, U.S. Life Ins.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	27,144	75,154 (0%)	0%		-	Common Stock
Jazz Pharma PLC	Neena M. Patil	EVP & Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	27,084	0	-		-	Non-Qualified Stock Option (right to buy)
Jazz Pharma PLC	Neena M. Patil	EVP & Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 137.12 per share.	26 Feb 2026	27,084	83,946 (0%)	0%	137.1	3,713,758	Ordinary Shares
Enviri Corp	Jeffrey A. Beswick	SVP & Grp. Pres., Clean Earth	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share.	26 Feb 2026	26,288	99,413 (0%)	0%	18.6	488,694	Common Stock
Coeur Mining Inc	Thomas S. Whelan	EVP & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.56 per share.	26 Feb 2026	26,020	682,119 (0%)	0%	26.6	691,091	Common Stock, par value $0.01 per share
Brown & Brown	R. Andrew Watts	EVP, CFO and Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	26,010	84,160 (0%)	0%		0	Common Stock, $.10 par value (2019 SIP)
Nu Skin Enterprises Inc (Class A)	Steven Keith Hatchett	Chief Product Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.63 per share.	26 Feb 2026	26,001	182,877 (0%)	0%	8.6	224,389	Class A Common Stock
Talen Energy Corp - Ordinary Shares New	Cole Muller	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,934	25,934	-		-	2026 Performance-Based Restricted Stock Units
Stem Inc (Class A)	Michael James Carlson	President, Managed Services	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,800	25,800	-		-	Restricted Stock Unit
Stem Inc (Class A)	Matthew Tappin	President, Software Products	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,800	25,800	-		-	Restricted Stock Unit
Stem Inc (Class A)	Brian Musfeldt	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,800	25,800	-		-	Restricted Stock Unit
Wells Fargo Rising Revenue	Kristy Fercho	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,682	25,682	-		-	2023 Performance Shares
International Seaways Inc	Lois K. Zabrocky	Director, President & CEO	Other type of transaction at price $ 0.00 per share.	26 Feb 2026	25,632	210,262 (0%)	0%		-	Common Stock, no par value per share
IBM Industry Headwinds	Anne E. Robinson	Senior Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,363	25,363	-		-	Emp. Stock Option (right to buy)
Genworth Fin Inc (Class A)	Gregory S. Karawan	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	25,316	50,633	-		-	Restricted Stock Units
Genworth Fin Inc (Class A)	Gregory S. Karawan	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2026	25,316	362,743 (0%)	0%		-	Common Stock
IBM Industry Headwinds	Nickle Jaclyn Lamoreaux	Senior Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,138	25,138	-		-	Emp. Stock Option (right to buy)
Viavi Soln Inc	Donald A. Colvin	Director	Sale of securities on an exchange or to another person at price $ 29.23 per share.	26 Feb 2026	25,000	147,053 (0%)	0%	29.2	730,750	Common Stock
Axsome Therapeutics Inc	Mark Coleman	Director	Sale of securities on an exchange or to another person at price $ 161.11 per share.	26 Feb 2026	25,000	47,140 (0%)	0%	161.1	4,027,750	Common Stock
Range Resources Corp Results	Christian S. Kendall	Director	Grant, award, or other acquisition of securities at price $ 38.83 per share.	26 Feb 2026	25,000	26,106 (0%)	0%	38.8	970,710	Common Stock
Silgan Holdings Inc	Shawn C. Fabry	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,000	77,513 (0%)	0%		-	Common Stock
Silgan Holdings Inc	Alexander G. Hutter	SVP, Strategy and IR	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,000	43,511 (0%)	0%		-	Common Stock
Indaptus Therapeutics Inc	Jerome D. Jabbour	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2026	25,000	25,000	-		-	Option to Buy Common Stock
Bausch + Lomb Corp	Brenton L. Saunders	Director, CEO and Chairman of the Board	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.30 per share.	26 Feb 2026	24,649	951,875	-	18.3	451,077	Common Shares, No Par Value

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Feb 26, 2026

Monitor US insider transactions and discover insider buying and selling of stocks on Feb 26, 2026.

Screeners based on Insider Trading parameters